---
title: "ScopusAIReviews"
format: html
editor: visual
---

# what are some outstanding questions related to diabetes, diabetes management, access to medications

**Outstanding Questions Related to Diabetes, Diabetes Management, and Access to Medications**

**1. Access to Medications:**

- **Affordability and Availability:** One of the primary concerns is the affordability and availability of diabetes medications. Despite the availability of generic medications, financial barriers remain significant, especially in low- and middle-income countries (LMICs) [1] [2] [3] . The cost of newer treatments also poses a challenge, necessitating a balance between clinical benefits and financial impacts [3] .

- **Inequalities in Access:** There are notable inequalities in access to diabetes medications based on socioeconomic status, education, and geographic location. People in remote areas, those with lower education, and the poor often have less access to necessary medications [2] [4] .

- **Government and Policy Role:** The level of government commitment and the presence of operational diabetes policies significantly influence access to medications. Effective policies should include financial protections, price regulations, and decentralized service delivery [4] [5] .

**2. Diabetes Management:**

- **Patient-Centered Care:** There is a need for more patient-centered research and management strategies. Many existing 
studies do not focus on patient-specific questions and concerns, highlighting a gap in the literature and practice [6] .

- **Education and Self-Care:** Effective diabetes management requires comprehensive education that enhances patients' and their families' self-care capacities. This includes proper medication use, lifestyle changes, and routine monitoring [7] [8] .

- **Pharmacist Involvement:** Pharmacists play a crucial role in diabetes management, particularly in providing medication advice, ensuring proper storage and use of insulin, and supporting patients with intellectual disabilities [9] [10] .

**3. Research and Future Directions:**

- **Social Determinants of Health:** Further research is needed to understand the social determinants of health that affect medication access and diabetes management, particularly in LMICs [2] .

- **Implementation of Existing Research:** There is a need to transition from research to implementation, ensuring that existing knowledge is applied in practice to improve diabetes management and outcomes [6] .

- **Technological Advancements:** Modern technologies and informatics can aid in organizing patient care, tracking progress, and providing personalized management plans [11] [12] .

**Summary Table:**

| **Area**                  | **Outstanding Questions**                                                                 |
|---------------------------|-------------------------------------------------------------------------------------------|
| **Access to Medications** | - How can affordability and availability of medications be improved?                      |
|                           | - What policies can reduce inequalities in medication access?                             |
| **Diabetes Management**   | - How can patient-centered care be better integrated into diabetes management?            |
|                           | - What educational strategies are most effective for enhancing self-care?                 |
|                           | - How can pharmacists be more effectively utilized in diabetes care?                      |
| **Research Directions**   | - What are the social determinants affecting diabetes management in different regions?    |
|                           | - How can existing research be implemented to improve patient outcomes?                   |
|                           | - What role can modern technologies play in enhancing diabetes management?                |

These questions highlight the multifaceted challenges in diabetes care and the need for comprehensive strategies involving policy, education, and research to address them effectively.

References
1. Access to diabetes care and treatment in africa: Challenges and opportunities
Beran, D., Besançon, S.
Medecine et Sante Tropicales, 2019
https://www.scopus.com/record/display.uri?eid=2-s2.0-85059691308&origin=scopusAI

2. Assessing evidence of inequalities in access to medication for diabetic populations in low- and middle-income countries: A systematic review
Christiani, Y., Dhippayom, T., Chaiyakunapruk, N.
Global Health Action, 2016
https://www.scopus.com/record/display.uri?eid=2-s2.0-85015763873&origin=scopusAI

3. Availability and Affordability of Essential Medicines: Implications for Global Diabetes Treatment
Beran, D., Ewen, M., Lipska, K., (...), Yudkin, J.S.
Current Diabetes Reports, 2018
https://www.scopus.com/record/display.uri?eid=2-s2.0-85048710760&origin=scopusAI

4. Barriers and Facilitators in Access to Diabetes, Hypertension, and Dyslipidemia Medicines: A Scoping Review
Castillo-Laborde, C., Hirmas-Adauy, M., Matute, I., (...), Plass, B.
Public Health Reviews, 2022
https://www.scopus.com/record/display.uri?eid=2-s2.0-85138131523&origin=scopusAI

5. Perceptions of diabetes patients and their caregivers regarding access to medicine in a severely constrained health system: A qualitative study in Harare, Zimbabwe
Mureyi, D., Katena, N.A., Monera-Penduka, T.
PLOS Global Public Health, 2022
https://www.scopus.com/record/display.uri?eid=2-s2.0-85171172481&origin=scopusAI

6. Patient Centered Studies Focused on Type 2 Diabetes Management, Educa-tion, and Family Support: A Scoping Review
Arnold, A., Rosenthal, M., Salkar, M., (...), Mancuso, B.
Current Diabetes Reviews, 2022
https://www.scopus.com/record/display.uri?eid=2-s2.0-85130352814&origin=scopusAI

7. Brief Overview of Diabetes, the Disease
Dunning AM, T.
Diabetes Education: Art, Science and Evidence, 2013
https://www.scopus.com/record/display.uri?eid=2-s2.0-84885499368&origin=scopusAI

8. Patients' knowledge regarding medication therapy to treat diabetes: A challenge for health care services
Faria, H.T.G., Zanetti, M.L., Antônio dos Santos, M., De Souza Teixeira, C.R.
ACTA Paulista de Enfermagem, 2009
https://www.scopus.com/record/display.uri?eid=2-s2.0-77949418533&origin=scopusAI

9. Pharmacists report lack of reinforcement and the work environment as the biggest barriers to routine monitoring and follow-up for people with diabetes: A survey of community pharmacists
MacCallum, L., Mathers, A., Kellar, J., (...), Dolovich, L.
Research in Social and Administrative Pharmacy, 2021
https://www.scopus.com/record/display.uri?eid=2-s2.0-85083424707&origin=scopusAI

10. Case study: Hidden complexity of medicines use: Information provided by a person with intellectual disability and diabetes to a pharmacist
Flood, B., Henman, M.C.
British Journal of Learning Disabilities, 2015
https://www.scopus.com/record/display.uri?eid=2-s2.0-84937728253&origin=scopusAI

11. Increasing patient empowerment and improving diabetes care by utilizing a computer-based patient "roadmap".
Barnes, C.S., Tsui, C., Caudle, J., (...), Ziemer, D.C.
AMIA ... Annual Symposium proceedings / AMIA Symposium. AMIA Symposium, 2006
https://www.scopus.com/record/display.uri?eid=2-s2.0-34748922859&origin=scopusAI

12. Green Healer Anti-Diabetic Nanomedicine for the Management of Diabetes Mellitus
Hajam, Y.A., Kumar, R.
Green Healer Anti-Diabetic Nanomedicine for the Management of Diabetes Mellitus, 2023
https://www.scopus.com/record/display.uri?eid=2-s2.0-85165324687&origin=scopusAI

# How do sociodemographic and social determinants of health affect diabetes medication use, particularly more modern medications like GLP-1, and diabetes control

**Impact of Sociodemographic and Social Determinants of Health on Diabetes Medication Use and Control**

**Sociodemographic Factors:**

- **Income and Education:** Higher socioeconomic position, including higher income and education levels, is associated with better glycemic control over time [1] [2] [3] . Lower income levels are linked to reduced likelihood of using newer antidiabetic medications like GLP-1 receptor agonists [4] [5] .

- **Age and Gender:** Older age and male gender are associated with better medication adherence [6] [7] . Younger age and rural residence are linked to poorer glycemic control [8] .

- **Race and Ethnicity:** Non-Hispanic Black individuals are less likely to use newer antidiabetic drugs compared to non-Hispanic White individuals [4] . Racial and ethnic minorities often face disparities in diabetes management and outcomes due to socioeconomic and structural factors [9] [10] [11] .

**Social Determinants of Health (SDoH:**

- **Neighborhood and Environment:** Living in neighborhoods with high deprivation or a high percentage of vacant addresses is associated with lower use of newer antidiabetic medications [4] . Neighborhood factors like food insecurity and social cohesion also impact glycemic control [9] [12] [13] .

- **Psychosocial Factors:** Psychological distress, self-efficacy, and social support significantly influence diabetes self-care and glycemic control [2] [3] [14] [15] . Higher self-efficacy and social support are associated with better self-care behaviors and glycemic control, while psychological distress has a negative impact [3] [14] .

- **Behavioral Factors:** Physical activity and diet are crucial for diabetes management. Sedentarism and poor diet adherence are linked to lower medication adherence and poorer glycemic control [8] . Programs that enhance health literacy and provide social support can improve these behaviors [16] [17] .

**Medication Use and Adherence:**

- **GLP-1 Receptor Agonists:** These medications are effective in managing type 2 diabetes and promoting weight loss but are underutilized among lower-income and minority populations due to cost and access issues [5] [18] [19] [20] . Adherence to GLP-1 receptor agonists is influenced by factors such as medication cost, complexity of the regimen, and patient education [6] [7] [21] .

- **Barriers to Adherence:** Financial issues, transportation barriers, and lack of health insurance are significant barriers to medication adherence [5] [7] [22] . Addressing these barriers through comprehensive strategies, including pharmacist support and community health programs, can improve adherence and outcomes [16] [17] [20] .

**Conclusion:**
Sociodemographic and social determinants of health significantly impact the use of diabetes medications, particularly newer options like GLP-1 receptor agonists, and overall diabetes control. Addressing these determinants through targeted interventions and support systems is essential for improving diabetes management and reducing health disparities.

References
1. Association Between Social Determinants of Health and Glycemic Control Among African American People with Type 2 diabetes: The Jackson Heart Study
Hu, J., Kline, D.M., Tan, A., (...), Joseph, J.J.
Annals of Behavioral Medicine, 2022
https://www.scopus.com/record/display.uri?eid=2-s2.0-85142402861&origin=scopusAI

2. Social determinants of health in adults with type 2 diabetes-Contribution of mutable and immutable factors
Walker, R.J., Smalls, B.L., Egede, L.E.
Diabetes Research and Clinical Practice, 2015
https://www.scopus.com/record/display.uri?eid=2-s2.0-84949976720&origin=scopusAI

3. Independent effects of socioeconomic and psychological social determinants of health on self-care and outcomes in Type 2 diabetes
Walker, R.J., Gebregziabher, M., Martin-Harris, B., Egede, L.E.
General Hospital Psychiatry, 2014
https://www.scopus.com/record/display.uri?eid=2-s2.0-84919435660&origin=scopusAI

4. Impact of Contextual-Level Social Determinants of Health on Newer Antidiabetic Drug Adoption in Patients with Type 2 Diabetes
Li, Y., Hu, H., Zheng, Y., (...), Guo, J.
International Journal of Environmental Research and Public Health, 2023
https://www.scopus.com/record/display.uri?eid=2-s2.0-85149799537&origin=scopusAI

5. Use of Cardioprotective Antidiabetic Medications in Adults With and Without Cardiovascular Disease, 2015 to March 2020
Sherrill, C.H., Hwang, A.Y.
Annals of Pharmacotherapy, 2024
https://www.scopus.com/record/display.uri?eid=2-s2.0-85162666106&origin=scopusAI

6. Predictors of medication adherence in patients with type 2 diabetes mellitus
Curkendall, S.M., Thomas, N., Bell, K.F., (...), Weiss, A.J.
Current Medical Research and Opinion, 2013
https://www.scopus.com/record/display.uri?eid=2-s2.0-84884494635&origin=scopusAI

7. Drug therapy and medication adherence in type 2 diabetes in a care facility: A cross sectional survey
Eze, U.I.H., Akhumi, T.F., Iheanacho, C.O., Saka, S.A.
Exploratory Research in Clinical and Social Pharmacy, 2022
https://www.scopus.com/record/display.uri?eid=2-s2.0-85148562661&origin=scopusAI

8. Impact of adherence to Mediterranean diet and/or drug treatment on glycaemic control in type 2 diabetes mellitus patients: DM2-CUMCYL study
Sánchez-Hernández, M.S., Rodríguez-Caldero, M.C., Martín-Pérez, M.P., (...), Carratalá-Munuera, M.C.
Primary Care Diabetes, 2020
https://www.scopus.com/record/display.uri?eid=2-s2.0-85087903764&origin=scopusAI

9. Influence of Race, Ethnicity and Social Determinants of Health on Diabetes Outcomes
Walker, R.J., Strom Williams, J., Egede, L.E.
American Journal of the Medical Sciences, 2016
https://www.scopus.com/record/display.uri?eid=2-s2.0-85008674692&origin=scopusAI

10. Social and Structural Determinants of Cardiovascular Complications of Diabetes
Mensah, P., Valdez, K., Gyawali, A., Snell-Bergeon, J.
Current Diabetes Reports, 2024
https://www.scopus.com/record/display.uri?eid=2-s2.0-85191939825&origin=scopusAI

11. Moving Diabetes Upstream: the Social Determinants of Diabetes Management and Control Among Immigrants in the US
Martinez-Cardoso, A., Jang, W., Baig, A.A.
Current Diabetes Reports, 2020
https://www.scopus.com/record/display.uri?eid=2-s2.0-85089993701&origin=scopusAI

12. Food insecurity, SNAP participation and glycemic control in low-income adults with predominantly type 2 diabetes: A cross-sectional analysis using NHANES 2007-2018 data
Alawode, O., Humble, S., Herrick, C.J.
BMJ Open Diabetes Research and Care, 2023
https://www.scopus.com/record/display.uri?eid=2-s2.0-85159966338&origin=scopusAI

13. Social Determinants of Health and Diabetes-Related Distress in Patients With Insulin-Dependent Type 2 Diabetes: Cross-sectional, Mixed Methods Approach
Levy, N.K., Park, A., Solis, D., (...), Rogers, E.S.
JMIR Formative Research, 2022
https://www.scopus.com/record/display.uri?eid=2-s2.0-85144797085&origin=scopusAI

14. Quantifying direct effects of social determinants of health on glycemic control in adults with type 2 diabetes
Walker, R.J., Gebregziabher, M., Martin-Harris, B., Egede, L.E.
Diabetes Technology and Therapeutics, 2015
https://www.scopus.com/record/display.uri?eid=2-s2.0-84922453988&origin=scopusAI

15. Understanding the influence of psychological and socioeconomic factors on diabetes self-care using structured equation modeling
Walker, R.J., Gebregziabher, M., Martin-Harris, B., Egede, L.E.
Patient Education and Counseling, 2015
https://www.scopus.com/record/display.uri?eid=2-s2.0-84920031425&origin=scopusAI

16. Community-Based Efforts to Prevent and Manage Diabetes in Women Living in Vulnerable Communities
Lachance, L., Kelly, R.P., Wilkin, M., (...), Waddell, S.
Journal of Community Health, 2018
https://www.scopus.com/record/display.uri?eid=2-s2.0-85033559067&origin=scopusAI

17. A community integration approach to social determinants of health in New Mexico
McCloskey, J., Tollestrup, K., Sanders, M.
Family and Community Health, 2011
https://www.scopus.com/record/display.uri?eid=2-s2.0-78650872666&origin=scopusAI

18. Glucagon-like Peptide-1 Receptor Agonists in the Management of Type 2 Diabetes Mellitus and Obesity: The Impact of Pharmacological Properties and Genetic Factors
Klen, J., Dolžan, V.
International Journal of Molecular Sciences, 2022
https://www.scopus.com/record/display.uri?eid=2-s2.0-85126859888&origin=scopusAI

19. A clinical review of GLP-1 receptor agonists: Efficacy and safety in diabetes and beyond
Prasad-Reddy, L., Isaacs, D.
Drugs in Context, 2015
https://www.scopus.com/record/display.uri?eid=2-s2.0-84938932103&origin=scopusAI

20. Structural factors and their influence on the use of novel antidiabetic agents: Making the case for increased awareness and access to clinical pharmacy services
Trejos Kweyete, O.M., Woods, D., Okoumba, J., (...), Allen, J.M.
JACCP Journal of the American College of Clinical Pharmacy, 2025
https://www.scopus.com/record/display.uri?eid=2-s2.0-85210517448&origin=scopusAI

21. Medication Adherence and Associated Factors in Patients With Type 2 Diabetes: A Structural Equation Model
Huang, J., Ding, S., Xiong, S., Liu, Z.
Frontiers in Public Health, 2021
https://www.scopus.com/record/display.uri?eid=2-s2.0-85119418814&origin=scopusAI

22. Exploring Barriers and Facilitators to Glycemic Control and Shared Medical Appointment Engagement in Underserved Patients with Diabetes
Ganetsky, V.S., Shea, J.A., Szapary, C., (...), Long, J.A.
Journal of Health Care for the Poor and Underserved, 2022
https://www.scopus.com/record/display.uri?eid=2-s2.0-85124585442&origin=scopusAI

# What are current knowledge gaps in diabetes care that could be solved with data from continuous glucose monitors, activity records (like steps taken, heart rate), and machine learning methods?

To address the current knowledge gaps in diabetes care that could be solved with data from continuous glucose monitors (CGMs), activity records, and machine learning (ML) methods, several key areas can be identified:

### **Knowledge Gaps and Potential Solutions**

1. **Accurate Estimation of Food Intake and Physical Activity:**

   - **Current Gap:** Many individuals with diabetes struggle with accurately estimating and reporting their food intake and physical activity, leading to mismatches in insulin dosing and blood glucose levels [1] .
   
   - **Potential Solution:** ML algorithms can analyze historical patterns and interpret manual estimations of food intake and physical activity, combined with CGM data, to provide more accurate predictions and recommendations [1] .

2. **Prediction of Hypoglycemic and Hyperglycemic Events:**

   - **Current Gap:** There is a need for predictive models that can forecast hypoglycemic (<70 mg/dL) and hyperglycemic (>270 mg/dL) events to prevent acute complications [2] .
   
   - **Potential Solution:** ML models trained on CGM data can predict these events up to 60 minutes ahead of time, allowing for timely interventions [2] . Explainable ML techniques, such as SHAP, can help identify the most important features contributing to these predictions, enhancing the understanding and management of glucose control [2] .

3. **Personalized Diabetes Management:**

   - **Current Gap:** Diabetes management often lacks personalization, leading to suboptimal outcomes for some patients [3] .
   
   - **Potential Solution:** ML can leverage CGM data and activity records to create personalized treatment plans. Tools like TIDE can analyze CGM data to identify patients with deteriorating glucose control and provide personalized flags for timely interventions [4] .

4. **Integration of Diverse Data Sources:**
 
   - **Current Gap:** Effective diabetes management requires the integration of various data sources, including CGM, electronic health records, and patient-reported data, which is currently underutilized [5] .
   
   - **Potential Solution:** ML techniques can integrate and analyze these diverse data sources to generate actionable insights, improving the overall management of diabetes [5] .

5. **Addressing Alarm Fatigue and Data Overload:**
 
   - **Current Gap:** Users of CGM devices often experience alarm fatigue and data overload, which can reduce the effectiveness of these devices [3] [6] .
   
   - **Potential Solution:** ML algorithms can filter and prioritize alerts based on the severity and likelihood of events, reducing alarm fatigue and helping users focus on the most critical information [2] [3] .

6. **Improving Access and Utilization of CGM:**
 
   - **Current Gap:** Disparities in access to and utilization of CGM devices exist, often influenced by socioeconomic factors [3] [7] .
   
   - **Potential Solution:** Developing utilization measures and shared decision-making tools can help address these disparities and promote the routine use of CGM data in treatment and ongoing management [7] .

### **Summary Table**

| **Knowledge Gap**                              | **Potential Solution**                                                                 |
|------------------------------------------------|---------------------------------------------------------------------------------------|
| Accurate estimation of food intake and activity| ML algorithms to analyze historical patterns and sensor data [1]                       |
| Prediction of hypo/hyperglycemic events        | ML models for ahead-of-time risk predictions [2]                                       |
| Personalized diabetes management               | Tools like TIDE for personalized analysis and interventions [4]                        |
| Integration of diverse data sources            | ML techniques to integrate CGM, EHR, and patient-reported data [5]                     |
| Addressing alarm fatigue and data overload     | ML algorithms to filter and prioritize alerts [2] [3]                                  |
| Improving access and utilization of CGM        | Utilization measures and shared decision-making tools [7]                              |

By leveraging CGM data, activity records, and ML methods, these knowledge gaps can be addressed, leading to improved diabetes care and management.

References
1. Cloud recording for diabetes regulation of blood glucose concentrations
Dow, D.E., Urrea, M., Qin, I., Pham, T.
Proceedings - 2018 Joint 10th International Conference on Soft Computing and Intelligent Systems and 19th International Symposium on Advanced Intelligent Systems, SCIS-ISIS 2018, 2018
https://www.scopus.com/record/display.uri?eid=2-s2.0-85067100635&origin=scopusAI

2. Explainable Machine Learning for Real-Time Hypoglycemia and Hyperglycemia Prediction and Personalized Control Recommendations
Duckworth, C., Guy, M.J., Kumaran, A., (...), Boniface, M.
Journal of Diabetes Science and Technology, 2024
https://www.scopus.com/record/display.uri?eid=2-s2.0-85131858344&origin=scopusAI

3. Identifying the deficiencies of currently available CGM to improve uptake and benefit
Barnard-Kelly, K.D., Martínez-Brocca, M.A., Glatzer, T., Oliver, N.
Diabetic Medicine, 2024
https://www.scopus.com/record/display.uri?eid=2-s2.0-85192859186&origin=scopusAI

4. Algorithm-Enabled, Personalized Glucose Management for Type 1 Diabetes at the Population Scale: Prospective Evaluation in Clinical Practice
Scheinker, D., Gu, A., Grossman, J., (...), Prahalad, P.
JMIR Diabetes, 2022
https://www.scopus.com/record/display.uri?eid=2-s2.0-85132048642&origin=scopusAI

5. From data to insights
Khanam, A., Masoodi, F.S., Bamhdi, A.
A Biologist's Guide to Artificial Intelligence: Building the foundations of Artificial Intelligence and Machine Learning for Achieving Advancements in Life Sciences, 2024
https://www.scopus.com/record/display.uri?eid=2-s2.0-85189602813&origin=scopusAI

6. Limitations of Continuous Glucose Monitor Usage
Anhalt, H.
Diabetes Technology and Therapeutics, 2016
https://www.scopus.com/record/display.uri?eid=2-s2.0-84962527776&origin=scopusAI

7. Advancing Diabetes Quality Measurement in the Era of Continuous Glucose Monitoring
Khan, M., Wahid, N., Musser, T., (...), Aprigliano, C.
Science of Diabetes Self-Management and Care, 2023
https://www.scopus.com/record/display.uri?eid=2-s2.0-85152171078&origin=scopusAI

# What are current knowledge gaps in forecasting glucose levels using continuous glucose monitors

**Current Knowledge Gaps in Forecasting Glucose Levels Using Continuous Glucose Monitors (CGMs)**

Continuous glucose monitors (CGMs) have significantly advanced diabetes management by providing real-time data on glucose levels. However, several knowledge gaps and challenges remain in forecasting glucose levels accurately:

### **Physiological Delays and Accuracy**

- **Physiological Delay**: There is a notable delay between blood glucose levels and interstitial fluid (ISF) glucose levels, which CGMs measure. This delay can affect the timeliness and accuracy of glucose forecasts, potentially leading to delayed insulin dosing and increased risk of hyperglycemia or hypoglycemia [1] [2] [3] .

- **Accuracy of Predictions**: Current CGM systems often struggle with accuracy, particularly in predicting hypoglycemic events. The accuracy of predictive alerts is not yet optimal, and various models have been developed to address this, but none have achieved 100% accuracy [4] [5] .

### **Model Limitations**

- **Single Model Limitations**: Many existing prediction models, such as ARIMA, LSSVM, GRU, and LSTM, have limitations in capturing both linear and nonlinear characteristics of blood glucose trends. Hybrid models combining these approaches have been proposed to improve accuracy, but further validation is needed [6] [7] .

- **Short-term vs. Long-term Predictions**: Most research focuses on short-term glucose forecasting, often overlooking the need for accurate long-term predictions. Long-term forecasting (e.g. 60, 120, and 240 minutes) remains a critical area requiring more exploration and development [8] .

### **Data and Methodological Challenges**

- **Small and Private Datasets**: Many prediction methods are evaluated on small, private datasets, which impedes reproducibility and broader research efforts. There is a need for standardized prediction tasks and systematic comparisons 
between methods to identify the most effective tools [9] .

- **Behavioral Interventions**: Current research lacks computational approaches that recommend behavioral interventions (e.g. changes in diet, exercise) to bring glucose levels to a normal range. Integrating such recommendations could enhance the practical utility of CGM forecasts [10] .

### **Technological and Practical Issues**

- **Sensor Delays and Malfunctions**: CGM systems face challenges related to sensor delays (approximately 10 minutes between interstitial and plasma glucose readings) and potential malfunctions, complicating the interpretation of rapid glucose level changes [3] .

- **Wearability and User Compliance**: The success of CGM systems also depends on their wearability and user compliance. Ensuring that devices are comfortable and easy to use is crucial for their widespread adoption and effectiveness [5] .

### **Future Directions**

- **Improving Predictive Models**: Future research should focus on developing and validating more accurate predictive models, possibly through hybrid or ensemble approaches that combine the strengths of multiple models [3] .

- **Standardizing Data and Methods**: Establishing a consolidated repository of publicly available CGM datasets and standardized tasks can foster reproducibility and coordinated research efforts [9] .

- **Incorporating Behavioral Data**: Integrating behavioral data into predictive models can provide more comprehensive and actionable insights for managing glucose levels [10] .

By addressing these gaps, the accuracy and utility of CGM-based glucose forecasting can be significantly improved, leading to better diabetes management and patient outcomes.

References
1. Glucose Prediction using Wide-Deep LSTM Network for Accurate Insulin Dosing in Artificial Pancreas
Kalita, D., Mirza, K.B.
Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBS, 2022
https://www.scopus.com/record/display.uri?eid=2-s2.0-85138127590&origin=scopusAI

2. From self-monitoring of glucose to predictive continuous glucose monitoring
Otway, D., Gilmour, M.
Diabetic Hypoglycemia, 2013
https://www.scopus.com/record/display.uri?eid=2-s2.0-84879659718&origin=scopusAI

3. Comparative Analysis of Predictive Interstitial Glucose Level Classification Models
Kistkins, S., Mihailovs, T., Lobanovs, S., (...), Bļizņuks, D.
Sensors, 2023
https://www.scopus.com/record/display.uri?eid=2-s2.0-85174175775&origin=scopusAI

4. Prediction of blood glucose concentration ahead of time with feature based neural network
Shanthi, S., Kumar, D.
Malaysian Journal of Computer Science, 2012
https://www.scopus.com/record/display.uri?eid=2-s2.0-84871416229&origin=scopusAI

5. Continuous glucose monitoring: Current use and future directions
Desalvo, D., Buckingham, B.
Current Diabetes Reports, 2013
https://www.scopus.com/record/display.uri?eid=2-s2.0-84884589359&origin=scopusAI

6. Short-term prediction for dynamic blood glucose trends based on ARIMA-LSSVM-GRU model
Zhang, Y., Ning, Y., Li, B., (...), Dang, Y.
Journal of Physics: Conference Series, 2021
https://www.scopus.com/record/display.uri?eid=2-s2.0-85118457651&origin=scopusAI

7. Analysis and Comparison of Machine Learning Models for Glucose Forecasting
Simon, T., Zhang, J., Wang, S.
Lecture Notes in Networks and Systems, 2023
https://www.scopus.com/record/display.uri?eid=2-s2.0-85151047124&origin=scopusAI

8. Long-Term Predictive Analytics of Continuous Glucose Sensing for Enhanced Glycemic Control
Shuvo, M.M.H., Titirsha, T., Oliva, G., (...), Islam, S.K.
Proceedings of IEEE Computer Society Annual Symposium on VLSI, ISVLSI, 2024
https://www.scopus.com/record/display.uri?eid=2-s2.0-85206130619&origin=scopusAI

9. GLUCOBENCH: CURATED LIST OF CONTINUOUS GLUCOSE MONITORING DATASETS WITH PREDICTION BENCHMARKS
Sergazinov, R., Chun, E., Rogovchenko, V., (...), Gaynanova, I.
12th International Conference on Learning Representations, ICLR 2024, 2024
https://www.scopus.com/record/display.uri?eid=2-s2.0-85200601318&origin=scopusAI

10. GlySim: Modeling and Simulating Glycemic Response for Behavioral Lifestyle Interventions
Arefeen, A., Ghasemzadeh, H.
BHI 2023 - IEEE-EMBS International Conference on Biomedical and Health Informatics, Proceedings, 2023
https://www.scopus.com/record/display.uri?eid=2-s2.0-85179509015&origin=scopusAI

#Tell me about how wearable activity monitors have been used in conjunction with continuous glucose monitoring. What factors have been found to be best in predicting glucose levels into the future? What models or machine learning methods have worked best?

### Wearable Activity Monitors and Continuous Glucose Monitoring

**Integration of Wearable Activity Monitors with CGM:**

Wearable activity monitors, such as fitness trackers and smartwatches, have been increasingly integrated with continuous glucose monitoring (CGM) systems to enhance diabetes management. These devices can track physical activity, heart rate, sleep patterns, and other physiological parameters, which are crucial for understanding and predicting glucose fluctuations [1] [2] [3] [4] . The integration of these wearables with CGM allows for a more comprehensive monitoring system that can provide real-time data and insights into how various factors, including physical activity, affect glucose levels [1] [2] [3] .

**Factors Influencing Glucose Level Predictions:**

Several factors have been identified as significant in predicting future glucose levels:

- **Physical Activity:** Physical activity has a direct impact on glucose levels, and monitoring it can help in predicting glucose trends [1] [4] .

- **Meals and Insulin:** The timing and composition of meals, as well as insulin administration, are critical factors influencing glucose levels [1] .

- **Physiological Signals:** Heart rate, skin temperature, and electrodermal activity are among the physiological signals that can be used to predict glucose levels [4] [5] [6] [7] .

**Effective Models and Machine Learning Methods:**
Various machine learning models have been employed to predict glucose levels, with some showing more promise than others:

- **Long Short-Term Memory (LSTM) Networks:** LSTM models have been adapted to incorporate patient-specific data, showing high accuracy in predicting glucose levels up to 30 minutes in advance [8] [9] [10] .

- **Random Forest (RF) and Gradient Boosting Trees (GBT:** These models, especially when combined with pre-clustering techniques, have demonstrated high predictive accuracy for short-term glucose forecasts [11] [12] .

- **Support Vector Machines (SVM) and Decision Trees:** These models have also been used effectively, particularly when combined with features from wearable sensors [5] .

- **Autoregressive Integrated Moving Average (ARIMA) and Temporal Convolutional Networks (TCN:** These models have been effective in time-series forecasting of glucose levels, with TCNs being particularly robust against spurious oscillations [13] [14] .

**Summary of Key Models and Their Performance:**

| **Model** | **Prediction Horizon** | **Performance Metrics** | **Notes** |
|-----------|------------------------|-------------------------|-----------|
| LSTM | 30 minutes | >85% accuracy | High accuracy with patient-specific customization [8] [9]  |
| Random Forest (RF) | 45 minutes | Acceptable accuracy | Effective on constrained devices [11]  |
| Gradient Boosting Trees (GBT) | 15-30 minutes | High predictive accuracy | Enhanced with pre-clustering [12]  |
| ARIMA | 30 minutes | Low RMSE | Effective for time-series data [13]  |
| Temporal Convolutional Networks (TCN) | 30 minutes | Robust performance | Handles spurious oscillations well [13] [14]  |

**Conclusion:**
The integration of wearable activity monitors with CGM systems has significantly enhanced the ability to predict glucose levels by providing additional physiological data. Factors such as physical activity, meals, and physiological signals are crucial in these predictions. Among the various models, LSTM, RF, GBT, ARIMA, and TCN have shown the most promise, with each having specific strengths depending on the context and data available.

References
1. Sensor-Based Monitoring of Physical Activity for Glucose Management in Diabetic Patients: A Review
Campanella, S., Palma, L.
Lecture Notes in Electrical Engineering, 2025
https://www.scopus.com/record/display.uri?eid=2-s2.0-85215932776&origin=scopusAI

2. The Promise and Perils of Wearable Physiological Sensors for Diabetes Management
Schwartz, F.L., Marling, C.R., Bunescu, R.C.
Journal of Diabetes Science and Technology, 2018
https://www.scopus.com/record/display.uri?eid=2-s2.0-85044029665&origin=scopusAI

3. IoMT-Enabled Wearable Sensors for Continuous Glucose Monitoring in Diabetes Management
Edward Naveen, V., Jenefa, A., Ebenezer, V., (...), Solomon, I.
International Conference on Self Sustainable Artificial Intelligence Systems, ICSSAS 2023 - Proceedings, 2023
https://www.scopus.com/record/display.uri?eid=2-s2.0-85181061125&origin=scopusAI

4. Enhanced accuracy of continuous glucose monitoring during exercise through physical activity tracking integration
Sanz, A.J.L., Díez, J.L., Giménez, M., Bondia, J.
Sensors (Switzerland), 2019
https://www.scopus.com/record/display.uri?eid=2-s2.0-85071749002&origin=scopusAI

5. Prediction of Interstitial Glucose Levels Through Wearable Sensors Using Machine Learning
Ali, H., Madanian, S., Malik, N., (...), Niazi, I.K.
Proceedings of the 2023 IEEE Asia-Pacific Conference on Computer Science and Data Engineering, CSDE 2023, 2023
https://www.scopus.com/record/display.uri?eid=2-s2.0-85190610236&origin=scopusAI

6. Non-invasive wearables for remote monitoring of HbA1c and glucose variability: Proof of concept
Bent, B., Cho, P.J., Wittmann, A., (...), Dunn, J.P.
BMJ Open Diabetes Research and Care, 2021
https://www.scopus.com/record/display.uri?eid=2-s2.0-85108112179&origin=scopusAI

7. Detection of Hypoglycemia and Hyperglycemia Using Noninvasive Wearable Sensors: Electrocardiograms and Accelerometry
Dave, D., Vyas, K., Branan, K., (...), Erraguntla, M.
Journal of Diabetes Science and Technology, 2024
https://www.scopus.com/record/display.uri?eid=2-s2.0-85135519828&origin=scopusAI

8. Personalized Blood Glucose Forecasting Models Using Machine Learning
Jyoti, Saloni, S., Pathak, M.
2024 Asia Pacific Conference on Innovation in Technology, APCIT 2024, 2024
https://www.scopus.com/record/display.uri?eid=2-s2.0-85205549766&origin=scopusAI

9. A Comparison of Machine Learning Algorithms in Blood Glucose Prediction for People with Type 1 Diabetes
Wang, Y.
ACM International Conference Proceeding Series, 2021
https://www.scopus.com/record/display.uri?eid=2-s2.0-85122084356&origin=scopusAI

10. Leveraging deep learning models for continuous glucose monitoring and prediction in diabetes management: towards enhanced blood sugar control
Mohamed Yousuff, A.R., Zainulabedin Hasan, M., Anand, R., Rajasekhara Babu, M.
International Journal of System Assurance Engineering and Management, 2024
https://www.scopus.com/record/display.uri?eid=2-s2.0-85182407971&origin=scopusAI

11. Constrained IoT-Based Machine Learning for Accurate Glycemia Forecasting in Type 1 Diabetes Patients
Rodríguez-Rodríguez, I., Campo-Valera, M., Rodríguez, J.-V., Frisa-Rubio, A.
Sensors, 2023
https://www.scopus.com/record/display.uri?eid=2-s2.0-85152318327&origin=scopusAI

12. Machine Learning Algorithms Based on Time Series Pre-Clustering for Nocturnal Glucose Prediction in People with Type 1 Diabetes
Kladov, D.E., Berikov, V.B., Semenova, J.F., Klimontov, V.V.
Diagnostics, 2024
https://www.scopus.com/record/display.uri?eid=2-s2.0-85208368136&origin=scopusAI

13. Analysis and Comparison of Machine Learning Models for Glucose Forecasting
Simon, T., Zhang, J., Wang, S.
Lecture Notes in Networks and Systems, 2023
https://www.scopus.com/record/display.uri?eid=2-s2.0-85151047124&origin=scopusAI

14. Benchmarking Machine Learning Algorithms on Blood Glucose Prediction for Type i Diabetes in Comparison with Classical Time-Series Models
Xie, J., Wang, Q.
IEEE Transactions on Biomedical Engineering, 2020
https://www.scopus.com/record/display.uri?eid=2-s2.0-85092426708&origin=scopusAI
